SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models
Elizabeth Gray, Michelle Ulrich, Angela Epp, Patrick Younan, Disha Sahetya, Kelly Hensley, Sean Allred, Li-Ya Huang, Julie Hahn, Kristen Gahnberg, Piper M Treuting, Esther S Trueblood, John J Gosink, Robert Thurman, Serena Wo, Kellie Spahr, Evgenia Jane Haass, Katie Snead, Dannah Miller, Mary Padilla, Alyson J Smith, Chris Frantz, Jason P Schrum, Natalya Nazarenko, Shyra J Gardai
Journal for ImmunoTherapy of Cancer Oct 2023, 11 (10) e007572; DOI: 10.1136/jitc-2023-007572